April 2026 Rohto Pharmaceutical Co., Ltd. announced that its proprietary Licorice Extract Powder (Lyconin®)-derived ingredient Gliasperin B received Japan’s first functional food notification acceptance for a product using licorice-derived Gliasperin B as the functional ingredient. The product, developed by Rohto Group company MG Pharma Inc., was introduced as a functional food product focused on body fat management applications. Rohto stated that the development was based on its research into licorice extract and future plans include expanding ingredient proposals and product development with partner companies.
January 2026 Norevo GmbH expanded its licorice ingredient portfolio by highlighting multiple licorice extract formats, including granules, powders, pastes, and blocks, for applications in confectionery and food manufacturing. The company continued supporting manufacturers with customized licorice solutions for flavoring and functional ingredient applications.
January 2026 Natural Remedies Pvt. Ltd. announced a new clinical research initiative involving its patented GutGard® deglycyrrhizinated licorice (DGL) extract. The study focused on generating additional scientific evidence for GutGard® applications related to digestive health and wellness.
2025 Mafco Worldwide LLC continued promoting its Magnasweet® licorice extract portfolio, including specialty licorice-derived ingredients used in food, beverage, confectionery, oral care, and pharmaceutical applications. The company continued focusing on natural flavor modulation and functional ingredient solutions derived from licorice.